A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.
- Status
- COMPLETED
- Phase
- PHASE1
Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults
- Status
- TERMINATED
- Phase
- PHASE1
A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy Adults
- Status
- WITHDRAWN
- Phase
- PHASE1
Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab
- Status
- COMPLETED
- Phase
- N/A
LGX818 for Patients With BRAFV600 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)
- Status
- COMPLETED
- Phase
- PHASE1
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
- Status
- TERMINATED
- Phase
- PHASE3
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
- Status
- TERMINATED
- Phase
- PHASE3
Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease
- Status
- COMPLETED
- Phase
- PHASE4
The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease
- Status
- TERMINATED
- Phase
- PHASE4
A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
- Status
- COMPLETED
- Phase
- PHASE3